WESPAC Advisors SoCal’s Bristol-Myers Squibb BMY Stock Holding History

WESPAC Advisors SoCal’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-544	Closed	-$25K	–	111
2019 Q1	$25K	Hold	544	–	–	0.01%	151
2018 Q4	$28K	Sell	544 -200	-27%	-$10.7K	0.02%	151
2018 Q3	$46K	Buy	+744	New	+$44.2K	0.02%	131
2018 Q2	–	Sell	-544	Closed	-$34K	–	111
2018 Q1	$34K	Hold	544	–	–	0.02%	126
2017 Q4	$33K	Sell	544 -619	-53%	-$38.7K	0.02%	127
2017 Q3	$74K	Hold	1,163	–	–	0.04%	114
2017 Q2	$64K	Buy	1,163 +300	+35%	+$16.3K	0.04%	115
2017 Q1	$46.9K	Hold	863	–	–	0.03%	121
2016 Q4	$50.4K	Sell	863 -128	-13%	-$7K	0.03%	119
2016 Q3	$53.4K	Sell	991 -547	-36%	-$35.1K	0.04%	112
2016 Q2	$113K	Buy	1,538 +75	+5%	+$5.3K	0.07%	94
2016 Q1	$93.5K	Sell	1,463 -300	-17%	-$18.9K	0.07%	91
2015 Q4	$121K	Buy	+1,763	New	+$117K	0.08%	91

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WESPAC Advisors SoCal's BMY Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 544 shares — an estimated $25K sold.

WESPAC Advisors SoCal first reported a position in BMY in Q4 2015 and held it in 13 quarters. The position peaked at $121K in Q4 2015. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

WESPAC Advisors SoCal reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 544 Bristol-Myers Squibb shares in Q2 2019, an estimated $25K.
WESPAC Advisors SoCal first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 13 quarters.
WESPAC Advisors SoCal's Bristol-Myers Squibb position peaked at $121K in Q4 2015.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.